title: Uncovering the roles of miRNAs and their relationship with androgen receptor in prostate cancer.
abstract: Prostate cancer (PCa) is the second most commonly occurring malignant tumor in Europe and America. Normal and neoplastic growth of prostate gland are dependent on androgen receptor (AR) expression and function. PCa is driven by androgen and its receptor, and they continue to be the key drivers of castration-resistant prostate cancer (CRPC). CRPC is the terminal stage of PCa and seriously jeopardizes the patient's quality of life and lifespan. miRNAs are small noncoding RNAs, 18-25 nt in length that destabilize mRNA or repress protein synthesis by interacting with the 3'-untranslated regions (3'-UTR) of target mRNAs. miRNAs can regulate AR or be regulated by AR and then affect various signaling pathways related to cellular functions and tumor processes. In this review, we focus on the relationship between miRNAs and AR in PCa and elucidate their roles in the induction of malignant changes in PCa.
authors: Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing, Zhejiang Province, China.
authors: Song
authors: S
authors: ChunJiao
authors: Chen
authors: C
authors: Huan
authors: Xu
authors: X
authors: ChaoYang
authors: Ru
authors: R
authors: GuoMei
mesh_terms: D018450:Disease Progression; D005786:Gene Expression Regulation / Q000235:genetics / Q000502:physiology*; D006801:Humans; D008297:Male; D035683:MicroRNAs / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology*; D011944:Receptors, Androgen / Q000378:metabolism*
chemical_list: D035683:MicroRNAs; D011944:Receptors, Androgen
keywords: androgen receptor; castration-resistant prostate cancer; miRNAs; prostate cancer; target genes